. The Use of Biomedical Technologies for Cardiac Repair

One example of a technology used to deliver stem cells for cardiac repair is Percutaneous Intramyocardial Injection (PIMI). Advantages of this approach include minimal invasiveness, rapid recovery time, and ease of delivery. PIMI is a minimally invasive procedure, involving the injection of stem cells directly into the myocardium through a small catheter. This allows for the delivery of cells without the need for open-heart surgery and has the potential for quick patient recovery. Furthermore, this approach is relatively easy to use since it does not require highly specialized skills or tools. Drawbacks of PIMI include low efficacy of cell delivery, potential for cardiac damage, and unpredictable injections. The efficacy of cell delivery through PIMI is relatively low, due to difficulties ensuring that cells reach the target tissue. This can lead to inadequate healing of the cardiac tissue. Additionally, PIMI carries the risk of cardiac damage due to the injection itself, as well as the potential for air embolism. Lastly, the injection of cells is unpredictable, as it is difficult to control the exact placement of each cell. Overall, PIMI is a promising technology for the delivery of stem cells for cardiac repair, but it has several drawbacks that should be considered when choosing a delivery method.